NEW YORK, Jan. 4, 2017 /PRNewswire/ -- The Law Offices of
Vincent Wong announce that a class
action lawsuit has been commenced in the USDC for the Southern
District of California on behalf
of investors who purchased Ligand Pharmaceuticals Inc. (NASDAQ:
LGND) securities between November 9,
2015 and November 14,
2016.
Click here to learn about the case:
http://www.wongesq.com/pslra/ligand-pharmaceuticals. There
is no cost or obligation to you.
According to the complaint, during the Class Period, Defendants
made false and/or misleading statements and/or failed to disclose
that: (1) Ligand overstated the value of certain Deferred Tax
Assets by approximately $27.5
million; (2) Ligand's outstanding convertible senior
unsecured notes due 2019 should have been classified as short-term
debt rather than long-term debt as of December 31, 2015; (3) Ligand did not maintain
effective controls over the accuracy and presentation of the
accounting for income taxes related to complex transactions; (4) in
turn, Ligand lacked effective internal control over financial
reporting; and (5) as a result, Defendants' statements about
Ligand's business, operations and prospects were materially false
and misleading and/or lacked a reasonable basis at all relevant
times.
If you suffered a loss in Ligand you have until January 17, 2017 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn't require that you serve as a lead plaintiff. To
obtain additional information, contact Vincent Wong, Esq. either via email
vw@wongesq.com, by telephone at 212.425.1140, or visit
http://www.wongesq.com/pslra/ligand-pharmaceuticals.
Vincent Wong, Esq. is an
experienced attorney that has represented investors in securities
litigations involving financial fraud and violations of shareholder
rights. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lgnd-investor-alert-the-law-offices-of-vincent-wong-reminds-investors-of-a-class-action-involving-ligand-pharmaceuticals-inc-and-a-lead-plaintiff-deadline-of-january-17-2017-300385642.html
SOURCE The Law Offices of Vincent
Wong